AVDL
NASDAQ
$21.64
Avadel Pharmaceuticals plc (AVDL)
Sector:
Healthcare
Market Cap
$2.10B
Revenue 5Y CAGR
+49.45%
Free Cash Flow Yield
1.63%
Price Chart
Valuation
Market Cap$2.10B
Forward P/E16.86
Profitability
Total Revenue (TTM)$249M
Gross Profit (TTM)$236M
EBITDA$6.25M
Profit Margin0%
Operating Margin2.5%
EPS-$0.00310
Financial Health
Free Cash Flow Yield1.63%
Growth & Risk
Revenue 5Y CAGR+49.45%
Sharpe Ratio2.00